Cellular/Molecular
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Changhai Cui, T. K. Booker, Roberta S. Allen, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Outi Salminen, Theresa Tritto, Christopher M. Butt, W. R. Allen, Jerry A. Stitzel, J. Michael McIntosh, Jim Boulter, Allan C. Collins and Stephen F. Heinemann
Journal of Neuroscience 3 December 2003, 23 (35) 11045-11053; DOI: https://doi.org/10.1523/JNEUROSCI.23-35-11045.2003
Changhai Cui
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
T. K. Booker
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Roberta S. Allen
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Sharon R. Grady
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Paul Whiteaker
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Michael J. Marks
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Outi Salminen
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Theresa Tritto
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Christopher M. Butt
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
W. R. Allen
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Jerry A. Stitzel
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
J. Michael McIntosh
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Jim Boulter
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Allan C. Collins
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
Stephen F. Heinemann
1Salk Institute for Biological Studies, La Jolla, California 92037,
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309,
3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930,
4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112,
5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and
6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850

Published eLetters
Guidelines
As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Neuroscience
Vol. 23, Issue 35
3 Dec 2003
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Changhai Cui, T. K. Booker, Roberta S. Allen, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Outi Salminen, Theresa Tritto, Christopher M. Butt, W. R. Allen, Jerry A. Stitzel, J. Michael McIntosh, Jim Boulter, Allan C. Collins, Stephen F. Heinemann
Journal of Neuroscience 3 December 2003, 23 (35) 11045-11053; DOI: 10.1523/JNEUROSCI.23-35-11045.2003
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Changhai Cui, T. K. Booker, Roberta S. Allen, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Outi Salminen, Theresa Tritto, Christopher M. Butt, W. R. Allen, Jerry A. Stitzel, J. Michael McIntosh, Jim Boulter, Allan C. Collins, Stephen F. Heinemann
Journal of Neuroscience 3 December 2003, 23 (35) 11045-11053; DOI: 10.1523/JNEUROSCI.23-35-11045.2003
Jump to section
Keywords
Responses to this article
Jump to comment:
No eLetters have been published for this article.